Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19543915 | 0.94 | ESR1 (0.33) | ESR1ESR2RXFP1 | |
| SCHEMBL19546282 | 0.94 | ESR1 (0.34) | ESR1ESR2RXFP1 | |
| SCHEMBL19543914 | 0.90 | TUBB4A (0.32) | — | |
| SCHEMBL19544015 | 0.90 | — | — | |
| SCHEMBL19544382 | 0.88 | TP53 (0.32) | TP53RXFP1 | |
| SCHEMBL19544161 | 0.87 | CYP1A1 (0.37) | TP53RXFP1 | |
| SCHEMBL19543921 | 0.87 | LIMK1 (0.30) | — | |
| SCHEMBL19546304 | 0.87 | LIMK1 (0.30) | — | |
| SCHEMBL19546688 | 0.87 | FLT3 (0.33) | — | |
| SCHEMBL19986040 | 0.86 | TP53 (0.31) | TP53RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11008280-B2 | Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element | DUK SAN NEOLUX CO., LTD. (KR) | 2021-05-18 | — | — | US | disclosed |
| US-10797247-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-10-06 | — | — | US | disclosed |
| US-20190135730-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | DUK SAN NEOLUX CO., LTD. (KR) | 2019-05-09 | — | — | US | disclosed |
| US-20180102486-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-04-12 | — | — | US | disclosed |
| US-20180102486-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10797247-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, ORAI2, TRPV2 | ESR1 28/4885ESR2 187/4885TP53 2726/4885 |
| US-20180102486-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, TRPV2 | ESR1 28/4885ESR2 187/4885TP53 2726/4885 |
| US-11008280-B2 | Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element | ORAI2, PIEZO1, ORC3 | ESR1 14/4885ESR2 132/4885TP53 2688/4885 |
| US-20190135730-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | ORAI2, PIEZO1, ORC3 | ESR1 14/4885ESR2 132/4885TP53 2688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.